Gallium-PSMA PET/CT

Positron Emission Tomography

It’s a regular PET/CT examination from skull to mid-thigh after intravenous injection of the radioactive material (Gallium-Prostate Specific Membrane Antigen), which attaches to and identifies prostate cancer cells locally in the prostate as well as its metastasis all over the body.

Available in Egypt only at Misr Radiology Center

THE FUTURE in cancer prostate imaging

It’s very sensitive to prostate cancer cells, it detects the location of cancer cells accurately at a very early stage and at very low PSA levels before all other modalities.

  1. Localization of tumor tissue in recurrent prostate cancer in the setting of biochemical recurrence specially with low PSA values between 0.2 and 10 ng/mL to identify the site of recurrence.
  2. Primary staging in intermediate to high risk prostate cancer before surgical procedures or planning external beam radiation, where the likelihood of lymph node, bone and other organs metastases is increased. Misr Radiology Center offers a combined protocol of multi-parametric prostate MRI combined with Ga-PSMA PET/CT in a single report concluding the findings of both modalities together giving an accurate patient staging;
    • MRI in assessment of : local prostate staging using multi-parameters (T)
    • Ga-PSMA in assessment of : lymph nodes (N) , metastasis in the body (M) and confirmation of the prostatic lesion.
  3. Monitoring of systemic treatment in metastatic prostate cancer.
  4. Targeting biopsy after previous negative biopsy in patients with high suspicion of prostate cancer and prior negative biopsies as it has been shown to add in localization of primary prostate cancer.

RESERVE AN APPOINTMENT OR CONSULT A DOCTOR?

Call 19773 Now or Fill The Contact Form